The Impact of Shareholder Rights Litigation on Investors Overview LOS ANGELES, CA / ACCESSWIRE / December 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Flux Power Holdings, Inc. (“Flux Power” or “the Company”) (NASDAQ:FLUX) for violations of 10(b) and 20(a) of the…
The USD/JPY Rollercoaster Ride: Buckle Up! Buckle up, folks! The USD/JPY pair has been on a wild ride lately, reaching a five-month peak at the 158.00 neighborhood before taking a nosedive during the early European session on Friday. It seems like investors are looking past the recent Bank of Japan (BoJ) monetary policy update and…
Feeling the XRP Heat: A Rollercoaster Ride in the Crypto Market Hold onto your seats, crypto traders! Despite a recent 9% price drop, the optimism among XRP (CRYPTO: XRP) traders remains sky-high. Many are holding onto their positions, eagerly anticipating the upward momentum that seems just around the corner. Let’s break it down: XRP is…
Blog Post Article: Downgrading PG Stock Rating to HOLD A Closer Look at the Recent Developments After careful consideration, I have made the decision to downgrade my rating on PG stock to HOLD from my previous BUY rating. Several new catalysts have emerged since my last assessment, leading me to believe that there is no…
Dentsply Sirona Faces Class Action Lawsuit Overview ATLANTA, Dec. 19, 2024 (GLOBE NEWSWIRE) — A shareholder class action lawsuit has been filed against Dentsply Sirona Inc. (“Dentsply” or “the Company”) (NASDAQ: XRAY). The lawsuit alleges that Defendants made materially false or misleading statements and/or concealed material adverse facts about Dentsply’s business, operations, and prospects. Allegations…
Darden Restaurants, Inc. (NYSE:DRI) Q2 2025 Earnings Conference Call December 19, 2024 8:30 AM ET Company Participants: Phil McClain – Vice President, Finance and Investor Relations Rick Cardenas – President and Chief Executive Officer Raj Vennam – Senior Vice President and Chief Financial Officer Conference Call Participants: David Palmer – Evercore ISI Eric Gonzalez –…
The Impact of the FDA Decision on Eli Lilly’s Weight Loss Drug Background The Food and Drug Administration recently announced that the active ingredient in Eli Lilly’s weight loss drug Zepbound is no longer in shortage. This decision will have significant implications for both patients and compounding pharmacies. Transition Period During the 60 to 90-day…
Petros Pharmaceuticals Innovates with AI and Quantum Computing to Expand Patient Access to Drugs Company positions itself for new innovation utilizing AI and quantum computing to help expand patient access to drugs via OTC access NEW YORK, NY / ACCESSWIRE / December 19, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a company focused on expanding consumer…
